Biodesix was founded in 2005 to apply the principles of complex data analysis and mass spectrometry (MS) to the discovery and development of improved multivariate tests that give physicians better information to understand the patient and their disease. Understanding the clinically meaningful information contained within each patient’s molecular profile may improve diagnosis and therapeutic intervention…
Helsinn is a privately owned pharmaceutical group headquartered in Lugano, Switzerland, with operating subsidiaries in Ireland, the U.S. and an office in China. Helsinn is one of the world’s leading supportive cancer care companies. Our vision is to help people with cancer get the most of every day. We make everything we do, from the…
Overview Merck Vision Is to make a difference in the lives of people globally through their innovative medicines, vaccines, biologic therapies, consumer care and animal health products. They aspire to be the best healthcare company in the world and are dedicated to providing leading innovations and solutions for tomorrow. Merck Mission Is to discover, develop and provide…
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare…
Boehringer Ingelheim in Oncology We have a clear aspiration – to transform the lives of people with cancer by delivering meaningful advances, with the ultimate goal of curing a range of cancers. Our generational commitment to driving scientific innovation is reflected by our robust pipeline of cancer cell-directed and immuno-oncology investigational therapies, as well as…
At Takeda Oncology, we aspire to cure cancer, with inspiration from patients and innovation from everywhere. Our leadership in oncology extends more than 25 years and includes a range of therapies that have helped to transform the treatment landscape for previously underserved patient populations, in some cases shifting paradigms and becoming standard of care. We…
Founded more than 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California. For additional information about the company, please visit www.gene.com. About Genentech in…
Bristol Myers Squibb is committed to discovering, developing and delivering innovative medicines for the treatment of cancer. Our pipeline in oncology is robust, with several experimental anticancer compounds in development. It is also diverse, reflecting a range of modalities and research programs. One such area is immuno-oncology. Immuno-oncology represents an innovative approach to cancer research…
Astellas Oncology is committed to elevating the standard of cancer care. We focus on developing innovative, targeted therapies for hard-to-treat cancers with limited treatment options, which is where we see the greatest opportunity to help people living with cancer. Visit www.AstellasOncology.com. Reimbursement Hotline Local Account Manager: Maria Ramos-Person, MBA Tel: 813-545-4443 Toll-free: 1 (800) 477-6472…
Overview Alexion, AstraZeneca Rare Disease, is focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and delivery of life-changing medicines. A pioneering leader in rare disease for more than three decades, Alexion was the first to translate the complex biology of the complement system into transformative medicines,…
There’s a time when everything changes. That life-altering moment when someone hears, “You have cancer.” That moment is what motivates everyone at Lilly Oncology. Patient TruAssist Program PatientOne Assistance Program Bridging the Biomarker Gaps Resources Did you know? More than 152,000 Florida residents will face a new cancer diagnosis this year. Each of these…
Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has…
Seagen Inc. discovers, develops and commercializes novel medicines for cancer. For more information, visit www.seagen.com.
© 2021 FLASCO | Premium Website Design by The HDG
